Updated On November 5, 2019 - 11:18am

CSP News & Updates- Heparin Shortage

Heparin Shortage

https://www.raps.org/news-and-articles/news-articles/2019/10/fda-us-heparin-supply-not-impacted-by-african-swi

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=353

Reason for the ShortagE

  • Fresenius Kabi has put heparin on a protective allocation due to a potential shortage of raw ingredient. The letter describing this in detail is available at the following link: https://www.fresenius-kabi.com/us/news/fresenius-kabi-responds-to-a-pote....
  • Hikma did not provide a reason for the shortage.
  • Mylan refuses to provide updated availability information.
  • Pfizer has heparin on shortage due to manufacturing delays.
  • Sagent has heparin on shortage due to manufacturing issues and increased demand.

FDA - Information on shortage

https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Heparin%20Sodium%20and%20Sodium%20Chloride%200.9per%20Injection&st=c&tab=tabs-1